“A 50-mg dose of Enbrel now costs patients $7,401.83 per month: 643% more than it cost when launched in 1998,” according to the allegations in the antitrust class action filed against Enbrel manufacturer Amgen Inc.
'Monopoly Prices'?: Big Pharma Co. Amgen Accused of Anticompetitive Conduct
Leave a Reply